SE9904750D0 - New formulation, use and method - Google Patents

New formulation, use and method

Info

Publication number
SE9904750D0
SE9904750D0 SE9904750A SE9904750A SE9904750D0 SE 9904750 D0 SE9904750 D0 SE 9904750D0 SE 9904750 A SE9904750 A SE 9904750A SE 9904750 A SE9904750 A SE 9904750A SE 9904750 D0 SE9904750 D0 SE 9904750D0
Authority
SE
Sweden
Prior art keywords
disorders
disorder
reboxetine
prodrugs
metabolites
Prior art date
Application number
SE9904750A
Other languages
English (en)
Swedish (sv)
Inventor
Ulla Hoeck
Bo Kreilgaard
Helle Kristensen
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Priority to SE9904750A priority Critical patent/SE9904750D0/xx
Publication of SE9904750D0 publication Critical patent/SE9904750D0/xx
Priority to EP00971947A priority patent/EP1244431A1/en
Priority to PCT/SE2000/001972 priority patent/WO2001047503A1/en
Priority to AU10681/01A priority patent/AU1068101A/en
Priority to ARP000105838A priority patent/AR026371A1/es
Priority to PE2000001219A priority patent/PE20011024A1/es
Priority to MYPI20006094A priority patent/MY133485A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE9904750A 1999-12-23 1999-12-23 New formulation, use and method SE9904750D0 (sv)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SE9904750A SE9904750D0 (sv) 1999-12-23 1999-12-23 New formulation, use and method
EP00971947A EP1244431A1 (en) 1999-12-23 2000-10-12 Transdermal administration of reboxetine
PCT/SE2000/001972 WO2001047503A1 (en) 1999-12-23 2000-10-12 Transdermal administration of reboxetine
AU10681/01A AU1068101A (en) 1999-12-23 2000-10-12 Transdermal administration of reboxetine
ARP000105838A AR026371A1 (es) 1999-12-23 2000-11-06 Nueva formulacion, uso y metodo
PE2000001219A PE20011024A1 (es) 1999-12-23 2000-11-15 Dispositivo transdermico de reboxetina, uso y metodo
MYPI20006094A MY133485A (en) 1999-12-23 2000-12-21 Transdermal administration of reboxetine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9904750A SE9904750D0 (sv) 1999-12-23 1999-12-23 New formulation, use and method

Publications (1)

Publication Number Publication Date
SE9904750D0 true SE9904750D0 (sv) 1999-12-23

Family

ID=20418276

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9904750A SE9904750D0 (sv) 1999-12-23 1999-12-23 New formulation, use and method

Country Status (7)

Country Link
EP (1) EP1244431A1 (xx)
AR (1) AR026371A1 (xx)
AU (1) AU1068101A (xx)
MY (1) MY133485A (xx)
PE (1) PE20011024A1 (xx)
SE (1) SE9904750D0 (xx)
WO (1) WO2001047503A1 (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK286669B6 (sk) 1999-07-01 2009-03-05 Pharmacia & Upjohn Company Použitie opticky čistého (S,S)-reboxetínu alebo jeho farmaceuticky prijateľnej soli na výrobu lieku na liečenie alebo prevenciu periférnej neuropatie
EP1459750B1 (en) * 1999-07-01 2005-06-01 Pharmacia & Upjohn Company LLC (S,S)-reboxetine for treating fibromyalgia and other somatoform disorders
US20030082225A1 (en) * 2001-10-19 2003-05-01 Mason Paul Arthur Sterile, breathable patch for treating wound pain
EP2338873A1 (en) 2009-12-22 2011-06-29 Gmeiner, Peter New aminotetraline derivatives
TWI754702B (zh) 2016-12-28 2022-02-11 德商Ｕｃｂ製藥有限公司 （氮雜）吲哚－和苯並呋喃－３－磺醯胺類
DE102017127433A1 (de) 2017-11-21 2019-05-23 Lts Lohmann Therapie-Systeme Ag TTS auf Basis von klebenden Weichmacher-Polymer-Matrices
US20190381056A1 (en) 2018-06-17 2019-12-19 Axsome Therapeutics, Inc. Compositions for delivery of reboxetine
TW202016088A (zh) 2018-06-19 2020-05-01 德商Ｕｃｂ製藥有限公司 吡啶基及吡基-（氮）吲哚磺醯胺
EP3584244A1 (en) 2018-06-20 2019-12-25 UCB Pharma GmbH Substituted alkoxypyridinyl indolsulfonamides
US20200147093A1 (en) 2018-10-15 2020-05-14 Axsome Therapeutics, Inc. Use of esreboxetine to treat nervous system disorders such as fibromyalgia
ES2969383T3 (es) 2019-06-17 2024-05-17 Ucb Pharma Gmbh Derivados de N-(fenil)-indol-3-sulfonamida y compuestos relacionados como moduladores de GPR17 para el tratamiento de trastornos del SNC tales como la esclerosis múltiple

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5155198A (en) * 1997-08-28 1999-03-22 Robert Murdock Method and composition for transdermal administration of pharmacologic agent

Also Published As

Publication number Publication date
AR026371A1 (es) 2003-02-05
WO2001047503A1 (en) 2001-07-05
EP1244431A1 (en) 2002-10-02
AU1068101A (en) 2001-07-09
PE20011024A1 (es) 2001-10-03
MY133485A (en) 2007-11-30

Similar Documents

Publication Publication Date Title
SE9904750D0 (sv) New formulation, use and method
EA200801488A1 (ru) Замещенные фенетиламины, обладающие серотонинергической и/или норэпинефринергической активностью
RS20120158A3 (xx) Fenil-piperazin derivati kao inhibitori resorbcije serotonina
NO20055208L (no) 4-(2-fenylsulfanyl-fenyl)-piperidinderivater som serotonin-reopptaksinhibitorer
ECSP16003103A (es) Compuestos heteroaromáticos y su uso como ligandos d1 de dopamina
BRPI0507986A (pt) composto, composição farmacêutica, método para o tratamento de obesidade, de distúrbio obsessivo compulsivo, de depressão, e de ansiedade em mamìferos, e, uso de um composto
JP2006143749A5 (xx)
NI201500066A (xx)
UA102379C2 (ru) Производные 7-азаиндола как селективные ингибиторы бета-гидроксистероида дегидрогеназы 1 типа
ATE459353T1 (de) Gaboxadol zur behandlung von depressionen und anderen affektiven störungen
NO20055206L (no) 4-(2-fenyloksyfenyl)-piperidin eller -1,2,3,6-tetrahydropyridinderivater som serotonin-reopptaksinhibitorer
RU2004112546A (ru) Частичная агонистическая активность в отношении d2 рецепторов допамина и/или ингибирующая активность в отношении норадреналина
WO2007058998A3 (en) Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties
EA200101110A1 (ru) Новые фармацевтические комбинации ингибиторов nos
DK1392700T3 (da) Antidepressive azaheterocyclylmethylderivater af 7,8-dihydro-1,6,9-trioxa-3-aza-cyclopenta[a]naphthalen
ATE334989T1 (de) Antidepressive azaheterocyclylmethyl-derivate von 2,3-dihydro-1,4-dioxino 2,3-föchinoxalin
BRPI0407569A (pt) uso de s-10-hidróxi-10, 11-diidro-carbamazepina para o tratamento de ansiendade e distúrbios bipolares
MXPA05010678A (es) Derivados de 4-(2-fenilsulfanil-fenil)-1,2,3,6-tetrahidropiridina como inhibidores de recaptacion de serotonina.
DE60312874D1 (de) Kombinationstherapie mit verwendung eines serotonin-wiederaufnahmehemmers
NO20005621L (no) Nye medikamentkombinasjoner
NO20085172L (no) 3-(1h-indol-3-yl)indan-1-ylaminderivater for behandlingen av depresjon og angst
CY1116959T1 (el) Υποκατεστημενες φαιναιθυλαμινες με σεροτονινεργικη ή/και νορεπινεφρινεργικη δραστικοτητα
SG141463A1 (en) 2-(1h-indolysulfanyl)-benzyl amine derivatives as ssri
UA81472C2 (en) 4-(2-phenylsulfanyl-phenyl)-piperidine derivatives as serotonin reuptake inhibitors
ATE296640T1 (de) Methode und mittel zur behandlung eines post- poliosyndroms